Stockman A, Emery P, Doyle T, Hopper J, Tait B, Muirden K
Rheumatology Unit, Royal Melbourne Hospital, Victoria, Australia.
J Rheumatol. 1991 Jul;18(7):1001-7.
One hundred and twelve hospital based outpatients with rheumatoid arthritis (mean duration +/- standard error, 10.7 +/- 0.9 years) were studied for radiological progression of the hands and wrists over a mean period of 26.5 +/- 0.5 months. The majority were taking slow acting antirheumatic drugs (SAARD). The rate of radiographic progression was positively and independently associated with the female sex (p less than 0.01), erythrocyte sedimentation rate (ESR, p less than 0.05) and HLA-DR1 (p less than 0.05). There was a negative association with HLA-DR4 (p less than 0.05) but this was no longer significant after adjusting for ESR. There was no relationship between the rate of radiological progression and the presence of rheumatoid factor, rheumatoid nodules and duration of treatment with SAARD.
对112名以医院为基础的类风湿性关节炎门诊患者(平均病程±标准误,10.7±0.9年)进行了研究,观察其手部和腕部在平均26.5±0.5个月期间的放射学进展情况。大多数患者正在服用慢作用抗风湿药物(SAARD)。放射学进展率与女性性别(p<0.01)、红细胞沉降率(ESR,p<0.05)和HLA-DR1(p<0.05)呈正相关且独立相关。与HLA-DR4呈负相关(p<0.05),但在调整ESR后不再显著。放射学进展率与类风湿因子、类风湿结节的存在以及SAARD治疗持续时间之间没有关系。